Growth and bone health in pediatric intestinal failure patients receiving long-term parenteral nutrition

被引:48
|
作者
Pichler, Judith [1 ,2 ]
Chomtho, Sirinuch [4 ,5 ]
Fewtrell, Mary [4 ]
Macdonald, Sarah [3 ]
Hill, Susan M. [2 ]
机构
[1] Med Univ Vienna, Dept Paediat & Adolescent Med, A-1090 Vienna, Austria
[2] Great Ormond St Hosp Natl Hlth Serv Fdn Trust, Dept Paediat Gastroenterol, London, England
[3] Great Ormond St Hosp Natl Hlth Serv Fdn Trust, Dietet Dept, London, England
[4] UCL, Inst Child Hlth, Childhood Nutr Res Ctr, London, England
[5] Chulalongkorn Univ, Fac Med, Dept Paediat, Bangkok 10330, Thailand
来源
关键词
INFLAMMATORY-BOWEL-DISEASE; BODY-MASS INDEX; ALUMINUM EXPOSURE; PRETERM INFANTS; CROHNS-DISEASE; CHILDREN; RETARDATION; CHILDHOOD; OSTEOPOROSIS; MANAGEMENT;
D O I
10.3945/ajcn.112.057935
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Children with chronic intestinal failure (IF) treated with long-term parenteral nutrition (PN) may present with low bone mineral density (BMD). The cause may reflect small body size or suboptimal bone mineralization. Objective: We assessed growth and bone health in children with severe IF. Design: Height, weight, and fracture history were recorded. The lumbar spine bone mass was measured in 45 consecutive patients (24 male subjects) aged 5-17 y receiving PN for a median of 5 y. BMD and bone mineral apparent density (BMAD) [ie, adjusted-for-height SD scores (SDSs)] were calculated. Results: Diagnoses were short bowel syndrome in 12 patients (27%), intestinal enteropathy in 20 patients (44%), and motility disorder in 13 patients (29%). Mean (+/- SD) weight, height, and body mass index SDSs were -0.8 +/- 1.3, -1.80 +/- 1.5, and 0.4 +/- 1.3, respectively. The height SDS was less than -2 in 23 children (50%). Patients with enteropathy or intestinal mucosal inflammation (associated with dysmotility or short bowel) were significantly shorter than patients without enteropathy (P = 0.007). The BMD SDS was -1.7 +/- 1.6, and the BMAD SDS was -1.4 +/- 1.5, independent of primary diagnosis or mucosal inflammation. Nineteen patients (42%) had low BMD (SDS less than -2.0), and 14 patients (31%) had low BMAD. In 25 patients studied at 1-2-y intervals, the BMD SDS fell significantly with time, whereas BMAD declined less, which suggested that a poor bone mineral accretion reflected poor growth. A total of 11 of 37 patients (24%) had nonpathologic fractures (P = 0.3 compared with the general population). Conclusions: Approximately 50% of children were short, and one-third of children had low BMD and BMAD. Children with enteropathy or intestinal mucosal inflammation are at greatest risk of growth failure. Close nutritional monitoring and bespoke PN should maximize the potential for growth and bone mass. Am J Clin Nutr 2013;97:1260-9.
引用
收藏
页码:1260 / 1269
页数:10
相关论文
共 50 条
  • [1] Ghrelin in Children with Intestinal Failure Receiving Long-term Parenteral Nutrition
    Vlug, L.
    Neelis, E.
    Delhanty, P.
    Visser, J.
    Huisman, M.
    Rings, E.
    Wijnen, R.
    Tabbers, M.
    de Koning, B.
    TRANSPLANTATION, 2021, 105 (7S) : S3 - S3
  • [2] Body composition in paediatric intestinal failure patients receiving long-term parenteral nutrition
    Pichler, Judith
    Chomtho, Sirinuch
    Fewtrell, Mary
    Macdonald, Sarah
    Hill, Susan
    ARCHIVES OF DISEASE IN CHILDHOOD, 2014, 99 (02) : 147 - 153
  • [3] Changes in gut microbiota and its metabolic activity in pediatric intestinal failure patients receiving long-term parenteral nutrition
    Neelis, Esther
    de Koning, Barbara
    Hulst, Jessie
    Papadopoulou, Rodanthi
    Kerbiriou, Caroline
    Rings, Edmond
    Wijnen, Rene
    Nichols, Ben
    Gerasimidis, Konstantinos
    TRANSPLANTATION, 2019, 103 : S14 - S15
  • [4] Ghrelin Levels in Children With Intestinal Failure Receiving Long-Term Parenteral Nutrition
    Vlug, Lotte E.
    Delhanty, Patric J. D.
    Neelis, Esther G.
    Huisman, Martin
    Visser, Jenny A.
    Rings, Edmond H. H. M.
    Wijnen, Rene M. H.
    Nagelkerke, Sjoerd C. J.
    Tabbers, Merit M.
    Hulst, Jessie M.
    de Koning, Barbara A. E.
    FRONTIERS IN NUTRITION, 2022, 9
  • [5] Iodine Supplementation for Pediatric Patients Receiving Long-Term Parenteral Nutrition
    Santoro, Jonathan D.
    Nespor, Colleen
    Poole, Robert L.
    Kerner, John A.
    NUTRITION IN CLINICAL PRACTICE, 2016, 31 (02) : 245 - 249
  • [6] Bone disease in patients receiving long-term home parenteral nutrition
    Blumsohn, A
    Baxter, JP
    Tate, JM
    Mole, PR
    Penington, CR
    GUT, 1999, 44 : A130 - A130
  • [7] PROGNOSIS OF PATIENTS WITH NONMALIGNANT CHRONIC INTESTINAL FAILURE RECEIVING LONG-TERM HOME PARENTERAL-NUTRITION
    MESSING, B
    LEMANN, M
    LANDAIS, P
    GOUTTEBEL, MC
    GERARDBONCOMPAIN, M
    SAUDIN, F
    VANGOSSUM, A
    BEAU, P
    GUEDON, C
    BARNOUD, D
    BELIAH, M
    JOYEUX, H
    BOULETREAU, P
    ROBERT, D
    MATUCHANSKY, C
    LEVERVE, X
    LEREBOURS, E
    CARPENTIER, Y
    RAMBAUD, JC
    GASTROENTEROLOGY, 1995, 108 (04) : 1005 - 1010
  • [8] Long-term parenteral nutrition and parenteral nutrition dependency in pediatric patients
    Gambarara, M
    Ferretti, F
    Papadatou, B
    Gastelli-Gattinara, G
    Diamanti, A
    Rivosecchi, M
    Bernardi, S
    Lucchetti, MC
    Capuano, L
    Castro, M
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (06) : 2543 - 2544
  • [9] Plasma Aluminum Concentrations in Pediatric Patients Receiving Long-Term Parenteral Nutrition
    Courtney-Martin, Glenda
    Kosar, Christina
    Campbell, Alison
    Avitzur, Yaron
    Wales, Paul W.
    Steinberg, Karen
    Harrison, Debra
    Chambers, Kathryn
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2015, 39 (05) : 578 - 585
  • [10] Chromium and zinc concentrations in pediatric patients receiving long-term parenteral nutrition
    Mouser, JF
    Hak, EB
    Helms, RA
    Christensen, ML
    Storm, MC
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (19) : 1950 - 1956